Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113308
Status:
COMPLETED
Last Update Posted:
2017-03-14
First Post:
2005-06-07
Brief Title:
COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Phase III 12-Week Multicentre Double-Blind Randomised Placebo- and Active Comparator-Controlled Parallel Group Study to Investigate the Efficacy and Safety of GW406381 5mg 10mg 25mg and 50mg Administered Orally Once Daily in Adults With Rheumatoid Arthritis
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being conducted to find out if an investigational drug called GW406381 can help people with rheumatoid arthritis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None